Imaging of tumor angiogenesis: Current approaches and future prospects

被引:34
作者
Daldrup-Link, Heike E. [1 ]
Simon, Gerhard H. [1 ]
Brasch, Robert C. [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Radiol, Ctr Pharmaceut & Mol Imaging, San Francisco, CA 94143 USA
关键词
macromolecular contrast agents; blood pool agents; Angiogenesis Imaging;
D O I
10.2174/138161206777698774
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Tumor angiogenesis imaging should provide non-invasive assays of tumor vascular characteristics to supplement the now conventional diagnostic imaging goals of depicting tumor location. size, and morphology. This article will review the Current status of angiogenesis imaging approaches. considering ultrasound, CT, MR. SPECT, PET and optical techniques with attention to their respective capabilities and limitations. As a group, these imaging methods have some potential to depict and quantify tumor microvascular features. including those considered to be functionally associated with tumor angiogenesis. Additionally, new molecule-specific imaging techniques may serve to depict those biochemical pathways and regulatory events that control blood vessel growth and proliferation. Non-invasive monitoring of anti-angiogenic therapies has great appeal and should find wide application for defining tumor microvascular and metabolic changes. because treatment-related changes in tumor morphology tend to occur rather late and are non-specific. Future developments are likely to include "fusion" or "hybrid" imaging methods. Superimposed data from MR imaging with spectroscopy. PET with CT and PET with MR should be able to integrate advantages of different modalities yielding comprehensive information about tumor structure, function and microenvironment.
引用
收藏
页码:2661 / 2672
页数:12
相关论文
共 88 条
[1]
AICHER KP, 1990, CANCER RES, V50, P7376
[2]
Dynamic contrast-enhanced brain perfusion imaging: Technique and clinical applications [J].
Aksoy, FG ;
Lev, MH .
SEMINARS IN ULTRASOUND CT AND MRI, 2000, 21 (06) :462-477
[3]
Blankenberg FG, 2004, J NUCL MED, V45, P1373
[4]
In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[5]
Molecular imaging of MMP expression and therapeutic MMP inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
ACADEMIC RADIOLOGY, 2002, 9 :S314-S315
[6]
Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model [J].
Bremer, C ;
Bredow, S ;
Mahmood, U ;
Weissleder, R ;
Tung, CH .
RADIOLOGY, 2001, 221 (02) :523-529
[7]
Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis [J].
Buadu, LD ;
Murakami, J ;
Murayama, S ;
Hashiguchi, N ;
Sakai, S ;
Masuda, K ;
Toyoshima, S ;
Kuroki, S ;
Ohno, S .
RADIOLOGY, 1996, 200 (03) :639-649
[8]
Cenic A, 1999, AM J NEURORADIOL, V20, P63
[9]
Cha Soonmee, 2003, Magn Reson Imaging Clin N Am, V11, P403, DOI 10.1016/S1064-9689(03)00066-7
[10]
A non-invasive approach for monitoring breast tumor cells during therapeutic intervention [J].
Chaudhuri, TR ;
Cao, ZH ;
Rodríguez-Burford, C ;
LoBuglio, AF ;
Zinn, KR .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (02) :205-212